Since we identified Ptprz1 as the only PTP-encoding gene displaying robust differential expression during primary osteoblast differentiation, where it is required to inhibit proliferation, we addressed the question, if Ptprz1-deficiency would increase OS incidence on a tumor-prone genetic background. This evidence concerns the gene PTPRZ1 and neoplasm.